Change - Announcement of Appointment::Appointment of Professor Koh Cher Chiew Francis as Audit and Risk Committee Chair

Issuer & Securities

Issuer/ Manager
MANULIFE US REAL ESTATE MANAGEMENT PTE. LTD.
Securities
MANULIFE US REIT - SG1CI1000004 - BTOU
Stapled Security
No

Announcement Details

Announcement Title
Change - Announcement of Appointment
Date &Time of Broadcast
14-Jun-2024 17:32:31
Status
New
Announcement Sub Title
Appointment of Professor Koh Cher Chiew Francis as Audit and Risk Committee Chair
Announcement Reference
SG240614OTHR5H7R
Submitted By (Co./ Ind. Name)
Daphne Chua
Designation
Company Secretary
Description (Please provide a detailed description of the event in the box below)
Appointment of Professor Koh Cher Chiew Francis as Audit and Risk Committee Chair.

Additional Details

Date Of Appointment
17/06/2024
Name Of Person
Professor Koh Cher Chiew Francis
Age
72
Country Of Principal Residence
Singapore
The Board's comments on this appointment (including rationale, selection criteria, board diversity considerations, and the search and nomination process)
The Board, having considered the recommendation and assessment by the Nominating and Remuneration Committee ("NRC") and the Audit and Risk Committee ("ARC") of Professor Koh Cher Chiew Francis' qualifications and past experience, has approved Professor Koh's appointment as ARC Chair.
Whether appointment is executive, and if so, the area of responsibility
No
Job Title (e.g. Lead ID, AC Chairman, AC Member etc.)
Independent and Non-Executive Director
Lead Independent Director
ARC Chair
NRC Member
Professional qualifications
Doctor of Philosophy
University of New South Wales, Australia

Master of Business Administration
University of British Columbia, Canada

Bachelor of Business Administration with Honours (Second Class Honours Upper Division)
University of Singapore

CGMA, Chartered Global Management Accountant
(U.K., U.S.A.)

FCMA, Chartered Institute of Management Accountants (U.K.)

CA, Institute of Singapore Chartered Accountants
Any relationship (including immediate family relationships) with any existing director, existing executive officer, the issuer and/ or substantial shareholder of the listed issuer or any of its principal subsidiaries
Nil
Conflict of interests (including any competing business)
Nil
Working experience and occupation(s) during the past 10 years
January 2021 to Present:
Emeritus Professor of Finance, Singapore Management University ("SMU")

July 2005 to December 2020
Practice Professor of Finance, SMU

July 2017 to July 2020:
Special Advisor, Office of the President,
SMU

July 2017 to December 2019:
Mapletree Professor of Real Estate, SMU

March 2003 to June 2019
Director, MSc in Wealth Management Programme, SMU

July 2012 to June 2017
Vice Provost (Special Projects), SMU
Undertaking submitted to the listed issuer in the form of Appendix 7.7 (Listing Rule 704(7)) Or Appendix 7H (Catalist Rule 704(6))
No
Shareholding interest in the listed issuer and its subsidiaries?
Yes
Shareholding Details
450,000 units in Manulife US REIT
# These fields are not applicable for announcements of appointments pursuant to Listing Rule 704 (9) or Catalist Rule 704 (8).
Past (for the last 5 years)
Ngee Ann Polytechnic Investment Committee (Member)

Ngee Ann Polytechnic Council (Member)

Helvetic Investments Pte. Ltd. (Advisor)

SMU (Special Advisor, Office of the President)

SMU (Mapletree Professor of Real Estate)

Eunoia Junior College (Member, College Advisory Committee)

Singapore College of Insurance (Member, Board of Governors)
Present
Singapore Management University (Emeritus Professor of Finance)

China Taiping Insurance (Singapore) Pte. Ltd. (Independent Non-Executive Director)

Drs Koh & Partners Pte. Ltd. (Secretary, Non-Executive Director)

The Singapore Chinese Girls School (Non-Executive Director)
(a) Whether at any time during the last 10 years, an application or a petition under any bankruptcy law of any jurisdiction was filed against him or against a partnership of which he was a partner at the time when he was a partner or at any time within 2 years from the date he ceased to be a partner?
No
(b) Whether at any time during the last 10 years, an application or a petition under any law of any jurisdiction was filed against an entity (not being a partnership) of which he was a director or an equivalent person or a key executive, at the time when he was a director or an equivalent person or a key executive of that entity or at any time within 2 years from the date he ceased to be a director or an equivalent person or a key executive of that entity, for the winding up or dissolution of that entity or, where that entity is the trustee of a business trust, that business trust, on the ground of insolvency?
No
(c) Whether there is any unsatisfied judgment against him?
No
(d) Whether he has ever been convicted of any offence, in Singapore or elsewhere, involving fraud or dishonesty which is punishable with imprisonment, or has been the subject of any criminal proceedings (including any pending criminal proceedings of which he is aware) for such purpose?
No
(e) Whether he has ever been convicted of any offence, in Singapore or elsewhere, involving a breach of any law or regulatory requirement that relates to the securities or futures industry in Singapore or elsewhere, or has been the subject of any criminal proceedings (including any pending criminal proceedings of which he is aware) for such breach?
No
(f) Whether at any time during the last 10 years, judgment has been entered against him in any civil proceedings in Singapore or elsewhere involving a breach of any law or regulatory requirement that relates to the securities or futures industry in Singapore or elsewhere, or a finding of fraud, misrepresentation or dishonesty on his part, or he has been the subject of any civil proceedings (including any pending civil proceedings of which he is aware) involving an allegation of fraud, misrepresentation or dishonesty on his part?
No
(g) Whether he has ever been convicted in Singapore or elsewhere of any offence in connection with the formation or management of any entity or business trust?
No
(h) Whether he has ever been disqualified from acting as a director or an equivalent person of any entity (including the trustee of a business trust), or from taking part directly or indirectly in the management of any entity or business trust?
No
(i) Whether he has ever been the subject of any order, judgment or ruling of any court, tribunal or governmental body, permanently or temporarily enjoining him from engaging in any type of business practice or activity?
No
(j) Whether he has ever, to his knowledge, been concerned with the management or conduct, in Singapore or elsewhere, of the affairs of :-
(i) any corporation which has been investigated for a breach of any law or regulatory requirement governing corporations in Singapore or elsewhere; or
No
(ii) any entity (not being a corporation) which has been investigated for a breach of any law or regulatory requirement governing such entities in Singapore or elsewhere; or
No
(iii) any business trust which has been investigated for a breach of any law or regulatory requirement governing business trusts in Singapore or elsewhere; or
No
(iv) any entity or business trust which has been investigated for a breach of any law or regulatory requirement that relates to the securities or futures industry in Singapore or elsewhere, in connection with any matter occurring or arising during that period when he was so concerned with the entity or business trust?
No
(k) Whether he has been the subject of any current or past investigation or disciplinary proceedings, or has been reprimanded or issued any warning, by the Monetary Authority of Singapore or any other regulatory authority, exchange, professional body or government agency, whether in Singapore or elsewhere?
No
Any prior experience as a director of an issuer listed on the Exchange?
Yes
If Yes, Please provide details of prior experience
Professor Koh Cher Chiew Francis has been a director of Manulife US Real Estate Management Pte. Ltd., manager of Manulife US REIT, since 21 October 2019.